Search research articles
Contact Us
Filters
Showing results (11-20 of 510) with videos related to
Page
of 51
Sort By:
European Urology
|
February 11, 2020
Docetaxel for Early Prostate Cancer: What Have We Learned?
Himisha Beltran, Michael J Morris
The Oncologist
|
April 17, 2003
Clinical approaches to osseous metastases in prostate cancer
Michael J Morris, Howard I Scher
Critical Reviews in Oncology/Hematology
|
July 10, 2003
Optimizing targeted therapy and developing novel outcome measures for patients with advanced prostate cancer at Memorial Sloan-Kettering Cancer Center
Michael J Morris, Howard I Scher
Cancer Journal (Sudbury, Mass.)
|
October 18, 2016
Prostate-Specific Membrane Antigen-Directed Therapy for Metastatic Castration-Resistant Prostate Cancer
Min Yuen Teo, Michael J Morris
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 4, 2016
Molecular Imaging and Targeted Radionuclide Therapy of Prostate Cancer
Wolfgang A Weber, Michael J Morris
Primary Care Respiratory Journal : Journal of the General Practice Airways Group
|
August 20, 2013
The flow-volume loop in inducible laryngeal obstruction: one component of the complete evaluation
Michael J Morris, Kent L Christopher
Instructional Course Lectures
|
June 9, 2017
Medial Unicompartmental Knee Arthroplasty
Andrew Barrister Richardson, Michael J Morris
Journal of Nuclear Medicine Technology
|
June 3, 2026
Integration of PSMA PET into the New Recommendations from Prostate Cancer Working Group 4 for Prostate Cancer Trials
Phillip H Kuo, Michael J Morris
Chest
|
November 6, 2010
Diagnostic criteria for the classification of vocal cord dysfunction
Michael J Morris, Kent L Christopher
European Journal of Nuclear Medicine and Molecular Imaging
|
January 24, 2007
(11)C-acetate PET imaging in prostate cancer
Michael J Morris, Howard I Scher
Page
of 51
Search research articles
Search
Showing results (11-20 of 510) with videos related to
Sort By:
Page
of 51
European Urology
|
February 11, 2020
Docetaxel for Early Prostate Cancer: What Have We Learned?
Himisha Beltran, Michael J Morris
The Oncologist
|
April 17, 2003
Clinical approaches to osseous metastases in prostate cancer
Michael J Morris, Howard I Scher
Critical Reviews in Oncology/Hematology
|
July 10, 2003
Optimizing targeted therapy and developing novel outcome measures for patients with advanced prostate cancer at Memorial Sloan-Kettering Cancer Center
Michael J Morris, Howard I Scher
Cancer Journal (Sudbury, Mass.)
|
October 18, 2016
Prostate-Specific Membrane Antigen-Directed Therapy for Metastatic Castration-Resistant Prostate Cancer
Min Yuen Teo, Michael J Morris
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 4, 2016
Molecular Imaging and Targeted Radionuclide Therapy of Prostate Cancer
Wolfgang A Weber, Michael J Morris
Primary Care Respiratory Journal : Journal of the General Practice Airways Group
|
August 20, 2013
The flow-volume loop in inducible laryngeal obstruction: one component of the complete evaluation
Michael J Morris, Kent L Christopher
Instructional Course Lectures
|
June 9, 2017
Medial Unicompartmental Knee Arthroplasty
Andrew Barrister Richardson, Michael J Morris
Journal of Nuclear Medicine Technology
|
June 3, 2026
Integration of PSMA PET into the New Recommendations from Prostate Cancer Working Group 4 for Prostate Cancer Trials
Phillip H Kuo, Michael J Morris
Chest
|
November 6, 2010
Diagnostic criteria for the classification of vocal cord dysfunction
Michael J Morris, Kent L Christopher
European Journal of Nuclear Medicine and Molecular Imaging
|
January 24, 2007
(11)C-acetate PET imaging in prostate cancer
Michael J Morris, Howard I Scher
Page
of 51